London, United Kingdom–(Newsfile Corp. – October 7, 2025) – Edison issues report on Percheron Therapeutics (ASX: PER) Percheron Therapeutics has reported final results from the Phase I dose escalation study of HMBD-002, its monoclonal antibody targeting VISTA, a novel immune checkpoint protein. The data confirmed the compound’s favourable safety and …
Read More »
Breaking News
- Visionstate Announces Closing of Previously Announced Private Placement
- Puma Exploration Announces Increase in Kinross’ Equity Stake
- David Sidoo Scholarship for Entrepreneurs Announces 2025 Recipient and Continues National Support for Undergraduate Innovators
- Record Resources Closes $1.9 Million Offering to Advance Strategic Growth Initiatives in Gabon, Africa
- Arrow Capital Management Inc. Announces ETF Distribution for Wavefront All-Weather Alternative Fund ETF
- Nexera Provides Corporate Update
- Volt Carbon Technologies Announces $175,000 Placement
- Two Hands Corporation Announces Financial Update
- NodeMeta Launches Community-Driven Environmental Initiative with New Sustainable Features
- CSE Bulletin: Halted for Fundamental Change – eXeBlock Technology Corporation (XBLK.X)
Matribhumi Samachar
Address : 125 - Rajiv Nagar, Vinayakpur, Kanpur - 208025
Mo. No.: 8303063085
Email: [email protected]
Managed By Y2KSOLUTION
Copyright © Matribhumi Samachar